Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts
Pablo Legorreta, CEO, highlighted strong 2024 performance, with Portfolio Receipts reaching $2.8 billion, at the high end of guidance and representing 13% growth in Royalty Receipts. He noted this ...
Saputo increases share buyback limit to 5% amid strong cash flow and cost-saving initiatives
CEO Carl Colizza highlighted the quarter’s performance, with adjusted EBITDA of $417 million, marking a 13% year-over-year increase, and the highest quarterly performance since Q3 2023. Revenue ...
Safehold targets multifamily expansion and $50M buyback in 2025
Q4 2024 Management View Jay Sugarman, Chairman and CEO, emphasized two key initiatives for 2025: expanding Safehold’s penetration in the multifamily affordable housing market and implementing a $50M ...
Great-West Lifeco signals 10% dividend increase and $500M share buyback with strong U.S. performance
Q4 2024 Management View CEO Paul Mahon highlighted record performance for the sixth consecutive quarter, driven by base earnings of $1.1 billion, a 15% increase year-over-year. The U.S. segment ...